Dana-Farber Cancer Institute · 5 hours ago
Regulatory Coordinator - Breast Oncology
Dana-Farber Cancer Institute is a leader in cancer research and patient care, and they are seeking a Regulatory Coordinator to support the regulatory requirements of clinical research projects in Breast Oncology. The role involves coordinating protocol submissions, maintaining regulatory compliance, and collaborating with various stakeholders in the clinical trials process.
CommunitiesHealth CareHealth DiagnosticsHospitalNon ProfitOncology
Responsibilities
Prepares and submits all protocol applications, amendments, continuing reviews, and informed consent documents for SRC and IRB review and approval
Prepares and submits regulatory documentation that may include IND/IDE applications, FDA annual reports, Serious Adverse Event reports, to the appropriate regulatory agencies including the Food and Drug Administration (FDA), Office of Biotechnology Activities (OBA), etc
Prepares, maintains and organizes Regulatory files for each assigned study in compliance with study sponsor requirement; Industry sponsor, DF/HCC sponsored etc
Maintains various regulatory tracking databases with information related to study recruitment, subject enrollment, and study progress and completion
Assists in the preparation and coordination of assigned study monitoring and auditing visits with study coordinator, Investigator, DF/HCC ODQ, Industry Sponsors, and third-party auditors
Track and manage assigned new protocol start-up packet; initiate, facilitate, and monitor study start-up progress to ensure established benchmarks are met
Communicate and collaborate with clinical trial key stakeholders through the start-up process, provide regular updates and ensure all start-up activities are completed
Create and maintain tracking for all subsequent submissions to the SRC/IRB; protocol & consent amendments, all required safety reporting, all required deviation, violation, exception, or other event reporting. Ensure various regulatory reporting required are met, Study Sponsor, FDA, IRB etc
Establishing and maintaining regular communication with study team, study sponsor, applicable regulatory agencies / offices to ensure all required information is relayed and responsible for the systematic documentation / tracking when applicable
Serve as facilitator for study team and sponsor regarding study status information, critical safety issues, upcoming protocol, consent and IDB amendments and applicable protocol training; responsible for the systematic documentation / tracking when applicable
Maintain working knowledge of current regulations, regulatory guidance and or local policies
Assists Clinical research Manager with regulatory based training and implementation of new or revised regulation, guidance and or local policy
Present regulatory status for disease group portfolio at applicable research meetings
Qualification
Required
Bachelor's degree or 1 year of experience as a Dana-Farber Associate Regulatory Coordinator
Excellent written and oral communication skills
Maintain confidentiality of information
Good decision-making and judgment
Attention to detail and follow-through skills
Demonstrated organization and time management/prioritization skills
Ability to work independently
Proficient in the use of computers, Microsoft applications and databases
Experience with medical terminology
Maintain working knowledge of current regulations, regulatory guidance and or local policies
Preferred
0-1 years of experience in a medical, scientific research, or technology-oriented business environment
Basic understanding of clinical trial conduct
Company
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research.
Funding
Current Stage
Late StageTotal Funding
$88.08MKey Investors
Elaine and Eduardo Saverin FoundationThe DeGregorio Family FoundationLlama
2025-11-24Grant· $20M
2025-05-06Grant· $1M
2024-09-24Grant· $0.5M
Recent News
Medical Xpress - latest medical and health news stories
2025-12-29
MarketScreener
2025-12-16
Company data provided by crunchbase